eBulletins

Publications

eBulletins

  • November 2018
    Tackling metabolic disorders - a Glucagon case study, our latest assay list, and more
  • October 2018
    The Impact of Biosimilars on Drug Development and Key Study Considerations
  • August 2018
    No matter the scale and scope of your study, whether it's local or international, Altasciences offers customized biostatistics services that suit your needs.
  • August 2018
    Do you have a Drug-Drug Interaction study in your pipeline? See the unique advantages Altasciences offers to complete quality DDI studies on time and cost-effectively.
  • July 2018
    Steps the FDA has taken to limit the misuse and abuse of prescription drugs, our tips on how to conduct a Human Abuse Potential (HAP) study, and a recent HAP case study.

Pages